These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34131943)

  • 1. Synthesis and properties of sildenafil isostere.
    Su Z; Zhang Q; Zhao Q; Liu W; Zhao T; Wang H; Li J; Xu J
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100145. PubMed ID: 34131943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors.
    Shaaban MA; Elshaier YAMM; Hammad AH; Farag NA; Hassan Haredy H; AbdEl-Ghany AA; Mohamed KO
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127337. PubMed ID: 32631538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and phosphodiesterase 5 inhibitory activity of new 5-phenyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one derivatives containing an N-acylamido group phenyl ring.
    Kim DK; Ryu DH; Lee N; Lee JY; Kim JS; Lee S; Choi JY; Ryu JH; Kim NH; Im GJ; Choi WS; Kim TK
    Bioorg Med Chem; 2001 Jul; 9(7):1895-9. PubMed ID: 11425592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxant effects of selected sildenafil analogues in the rat aorta.
    Mojzych M; Kubacka M; Mogilski S; Filipek B; Fornal E
    J Enzyme Inhib Med Chem; 2016; 31(3):381-8. PubMed ID: 25798686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Pyrazolo[4, 3-c]Quinolin-3-One Derivatives as PDE5A Inhibitors.
    Shaik A; Agarwal HK; Bhakuni R; Kirubakaran S
    Curr Top Med Chem; 2019; 19(4):305-315. PubMed ID: 30747070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitors.
    El-Sharkawy LY; El-Sakhawy RA; Abdel-Halim M; Lee K; Piazza GA; Ducho C; Hartmann RW; Abadi AH
    Arch Pharm (Weinheim); 2018 May; 351(5):e1800018. PubMed ID: 29656464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5.
    Sawant SD; Lakshma Reddy G; Dar MI; Srinivas M; Gupta G; Sahu PK; Mahajan P; Nargotra A; Singh S; Sharma SC; Tikoo M; Singh G; Vishwakarma RA; Syed SH
    Bioorg Med Chem; 2015 May; 23(9):2121-8. PubMed ID: 25801159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-(3-chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors.
    Sakamoto T; Koga Y; Hikota M; Matsuki K; Mochida H; Kikkawa K; Fujishige K; Kotera J; Omori K; Morimoto H; Yamada K
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1431-5. PubMed ID: 25754491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
    Somakala K; Tariq S; Amir M
    Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
    Abd El Hamid MK; Mihovilovic MD; El-Nassan HB
    Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
    Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors.
    Cherukupalli S; Chandrasekaran B; Kryštof V; Aleti RR; Sayyad N; Merugu SR; Kushwaha ND; Karpoormath R
    Bioorg Chem; 2018 Sep; 79():46-59. PubMed ID: 29753773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of some new 2-phenyl-3,6-pyridazinedione derivatives as PDE-5 inhibitors.
    Abd-Rabo ZS; George RF; Zaafar DK; Gawish AY; Serry AM
    Bioorg Chem; 2024 Apr; 145():107213. PubMed ID: 38368658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a new series of pyrazolo[1,5-a]pyrimidines as CDK2 inhibitors and anti-leukemia.
    Almehmadi SJ; Alsaedi AMR; Harras MF; Farghaly TA
    Bioorg Chem; 2021 Dec; 117():105431. PubMed ID: 34688130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors.
    Abdel-Halim M; Tinsley H; Keeton AB; Weam M; Atta NH; Hammam MA; Hefnawy A; Hartmann RW; Engel M; Piazza GA; Abadi AH
    Bioorg Chem; 2020 Nov; 104():104322. PubMed ID: 33142429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
    Azam MA; Dharanya L; Mehta CC; Sachdeva S
    Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.
    Abdellatif KRA; Bakr RB
    Bioorg Chem; 2018 Aug; 78():341-357. PubMed ID: 29627655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs.
    Attia MH; Elrazaz EZ; El-Emam SZ; Taher AT; Abdel-Aziz HA; Abouzid KAM
    Bioorg Chem; 2020 Jan; 94():103458. PubMed ID: 31785854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.